About this course

Learning Objectives

• Recognize clinical factors associated with response to pharmacotherapy versus psychotherapy versus their combination in mood disorders.
• Describe the relative effect sizes of current medications used to treat major mood, anxiety and psychotic disorders.
• Recognize predictors of placebo responsivity and of drug responsivity in clinical trials of mood, anxiety and psychotic disorders.

Course Instructor(s)

• 

  Joseph F. Goldberg, M.D.

  Joseph F. Goldberg, MD is Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. He attended college at the University of Chicago, graduate school in neuroscience at the University of Illinois-Chicago, and medical school at Northwestern University Medical School, then completed his psychiatry training and psychopharmacology research fellowship at the Payne Whitney Clinic of New York Presbyterian Hospital. His research has focused on the clinical phenomenology, treatment and outcome of mood disorders. He has published over 230 peer-reviewed papers on psychopharmacology and mood disorders, as well as four books, most recently "Practical Psychopharmacology: Translating Findings From Evidence-Based Trials into Real-World Clinical Practice” published in 2021 by Cambridge University Press. He is President-Elect of the American Society of Clinical Psychopharmacology and is an Editor for the Journal of Clinical Psychiatry. Dr. Goldberg is a Distinguished Life Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly's "America's Top Doctors.

Disclosure

References

• Arnow, B. A., Blasey, C., Williams, L. M., Palmer, D. M., Rekshan, W., Schatzberg, A. F., ... & Rush, A. J. (2015). Depression subtypes in predicting antidepressant response: a report from the iSPOT-D trial. American Journal of Psychiatry, 172(8), 743-750. https://doi.org/10.1176/appi.ajp.2015.14020181
• Goldberg, J. F., & Stahl, S. M. (2021). Practical psychopharmacology: Translating findings from evidence-based trials into real-world clinical practice. Cambridge University Press.
• Goldberg, J. F. (2018). When further pharmacotherapy seems futile. The Journal of Clinical Psychiatry, 80(1), 22421.
• Kelley, J. M., Kaptchuk, T. J., Cusin, C., Lipkin, S., & Fava, M. (2012). Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and psychosomatics, 81(5). doi: 10.1159/000337053
• Andrade, C. (2010). Stahl's essential psychopharmacology: neuroscientific basis and practical applications. Mens Sana Monographs, 8(1), 146. doi: 10.4103/0973-1229.58825